返回
Ascentage Pharma Group International (ASPHF) 財務
ASPHF 股價走勢圖
ASPHF 財務
Ascentage Pharma Group International
$8.48
0%
$0
收盤價：Mar 24, 16:00:00 GMT-4
$8.48
0%
$0
盤後：Mar 24, 20:00:00 GMT-4
關鍵數據
前收市價
$8.48
開盤價
$8.48
當日範圍
$8.48 - $8.48
52週區間
$5.82 - $10.65
交易量
100
平均成交量
59
股息收益率
--
每股盈餘 (TTM)
-0.52
市值
$788.3M
什麼是 ASCENTAGE PHARMA GROUP INTL？
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.